Application of Rituxmab in antibodymediated rejection among renal transplantation recipients

摘要

Objective To observe the indication,Safety and efficacy of a new immunosuppressant Rituximab in kidney transplantation. Methods Five patients,who were diagnosed as antibody mediated rejection ( AMR) from December 2010 to June 2011,were treated with single dose of Rituximab ( 500 mg ) and followed up for